Hudson Executive Capital LP
Affiliate at CANTALOUPE, INC.; Director at EAGLE PHARMACEUTICALS, INC.
- Sold, on record
- $2.6M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Feb 21, 2023
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- CANTALOUPE, INC.Affiliate
- EAGLE PHARMACEUTICALS, INC.Director
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Sales by company
- CANTALOUPE, INC.90,582 shares
- EAGLE PHARMACEUTICALS, INC.32,475 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale EAGLE PHARMACEUTICALS, INC.Plan not statedOct 18, 2019 2019
Sold 15,544 shares at $62.58 ($973k)
Hudson Executive Capital LP, Director
Sold 2% of holdings ($48.6M position)760,324 shares leftFirst sale on recordFiling
- 2 Form 4 sale EAGLE PHARMACEUTICALS, INC.Plan not statedOct 25, 2019 +7 days
Sold 16,931 shares at $63.48 ($1.1M)
Hudson Executive Capital LP, Director
Sold 2.3% of holdings ($47.6M position)732,777 shares leftFiling
- 3 Form 4 sale CANTALOUPE, INC.No planFeb 21, 2023 +1215 days
Sold 90,582 shares at $6.30 ($571k)
Hudson Executive Capital LP, 10% owner
No 10b5-1 planSold 1% of holdings ($59M position)9.3M shares leftFirst sale on recordFiling
- 4 Form 144 notice CANTALOUPE, INC.NoticeFeb 21, 2024 +365 days
Filed to sell 89,058 shares ($559k)
Hudson Executive Capital LP, Affiliate
No 10b5-1 planFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | Feb 21, 2024 | CANTALOUPE, INC. | Affiliate | Form 144 notice | 89,058 | $559k | Notice | SEC | |
| Feb 21, 2023 | Feb 21, 2024 | CANTALOUPE, INC. | 10% owner | Form 4 sale | 90,582 | $571k | 1.0% | No plan | SEC |
| Oct 25, 2019 | Oct 28, 2019 | EAGLE PHARMACEUTICALS, INC. | Director | Form 4 sale | 16,931 | $1.1M | 2.3% | Plan not stated | SEC |
| Oct 18, 2019 | Oct 18, 2019 | EAGLE PHARMACEUTICALS, INC. | Director | Form 4 sale | 15,544 | $973k | 2.0% | Plan not stated | SEC |